Capital RxSee all their emailsDecember Drug Pipeline & Clinical Newsletter
A real newsletter email from Capital Rx. Captured January 5, 2026.
Make this email yours
Migma AI designs one like it with your logo, colors, and images.
About this email
Captured Newsletter
Capital Rx's December newsletter provides updates on new drug approvals, focusing on Cardamyst™ (etripamil) nasal spray.
Minimalist design with a header image, followed by a title, introductory text, a highlighted section for approvals, and detailed drug information. Uses a light blue and white color scheme.
Color palette
Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.